AKCEA-APOCIII-LRx Archives - Medical Conferences

Antisense APOC3 oligonucleotide lowers triglyceride and atherogenic lipoproteins

Presented By

Prof. Jean-Claude Tardif, University of Montréal, Canada

Trial

Phase 2, AKCEA-APOCIII-LRx study

Conference

ESC 2020

5 November, 2020 12:54